INTERNATIONAL PATENT: NIKANG THERAPEUTICS, INC. FILES APPLICATION FOR "BIFUNCTIONAL COMPOUNDS CONTAINING PYRIDO[2,3-D]PYRIMIDIN-7(8H)-ONE DERIVATIVES FOR DEGRADING CYCLIN-DEPENDENT KINASES 2, 4 AND 6 VIA UBIQUITIN PROTEASOME PATHWAY"

GENEVA, July 3 -- NIKANG THERAPEUTICS, INC. (200 Powder Mill Road, BLDG E500San Francisco, Delaware 19803) filed a patent application (PCT/US2024/061182) for "BIFUNCTIONAL COMPOUNDS CONTAINING PYRIDO[2,3-D]PYRIMIDIN-7(8H)-ONE DERIVATIVES FOR DEGRADING CYCLIN-DEPENDENT KINASES 2, 4, AND 6 VIA UBIQUITIN PROTEASOME PATHWAY" on Dec 19, 2024. With publication no. WO/2025/137393, the details related to the patent application was published on Jun 26, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): YU, Zhiyong (c/o NiKang Therapeutics, Inc.200 Powder Mill Road, BLDG E500Wilmington, Delaware 19803), ...